Efficiency of dual siRNA-mediated gene therapy for intervertebral disc degeneration (IVDD)
- 1 May 2019
- journal article
- research article
- Published by Elsevier in The Spine Journal
- Vol. 19 (5) , 896-904
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Genetic polymorphisms associated with intervertebral disc degenerationThe Spine Journal, 2013
- Gene Therapy for Intervertebral Disk DegenerationOrthopedic Clinics of North America, 2011
- RNAi medicine for the brain: progresses and challengesHuman Molecular Genetics, 2011
- Caspase 3 as a therapeutic target for regulation of intervertebral disc degeneration in rabbitsArthritis & Rheumatism, 2011
- Inducible gene expression: diverse regulatory mechanismsNature Reviews Genetics, 2010
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticlesNature, 2010
- Effect of small interference RNA (siRNA) for ADAMTS5on intervertebral disc degeneration in the rabbit anular needle-puncture modelArthritis Research & Therapy, 2009
- In Vivo Growth Factor Treatment of Degenerated Intervertebral DiscsSpine, 2004
- 1999 Volvo Award Winner in Basic Science StudiesSpine, 1999
- Novel Series of Non-Glycerol-Based Cationic Transfection Lipids for Use in Liposomal Gene DeliveryJournal of Medicinal Chemistry, 1999